Cipla Limited (CIPLA) — Corporate Action | 17 April 2025
Cipla Limited allotted 23,282 fully paid-up equity shares of ₹2 each on 17th April 2025 under the Employee Stock Option Scheme 2013-A following employee option exercises. The company's issued and paid-up share capital increased to ₹1,61,52,80,804, comprising 80,76,40,402 equity shares. This represents a minor equity dilution from ESOP exercises.
About Cipla Limited (CIPLA)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when CIPLA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track CIPLA — Free💡 Ask AI about this filing
📊 More CIPLA filings
- Announcement — 11 August 2026 Cipla announced its ESG ratings from SES and NSE on August 11, 2026, showing a slight improvement in...
- Announcement — 4 August 2026 Cipla announced that its US subsidiary InvaGen closed a USFDA inspection at its Hauppauge facility, ...
- 🔴 Corporate Action — 31 July 2026 Cipla announced the allotment of 7,850 fully paid-up equity shares of INR 2 each under its ESOS 2013...
- Announcement — 27 July 2026 Cipla announced U.S. FDA approval for its generic version of Advair Diskus across all three strength...
- 🔴 Financial Results — 23 July 2026 Cipla reported consolidated revenue of INR 7,119 crores for Q1 FY27, up 2% YoY, with One India busin...
🔥 Also filed on 17 April 2025
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when CIPLA files new disclosures
Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track CIPLA — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research